Topics to be discussed include:
- G 4/19 – Double-patenting
- Plausibility - the expected G 2/21 referral
- Further case law covering both procedural as well as substantive issues, including experimental data, second medical use and dosage regimen claims.
- Tips on tactical behaviour and strategic aspects based on recent opposition and appeal cases